Draft guidance issued for consultation recommends the use of 4 AI technologies to help professionals detect fractures in ...

Studies have showed using TriageHF reduced all-cause hospitalisations by 58% according to Ahmed et al. (2024). Using ...

Donanemab (also called Kisunla and made by Eli Lilly) has been licensed today by the MHRA for treatment of mild cognitive impairment or mild dementia due to Alzheimer’s disease in some adults. It is a ...

There is a simple discount patient access scheme for danicopan. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

This guidance replaces NICE medtech innovation briefing 298 on TriageHF Plus for remotely monitoring people with cardiac implantable electronic devices at risk of heart failure or worsening heart ...

There is a simple discount patient access scheme for quizartinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact pasinfo@daiichi ...

The diagnostics advisory committee looked at evidence on algorithm-based remote monitoring of heart failure in people with cardiac implantable electronic devices (CIEDs). Evidence was considered from ...

This summary report is based on the NICE assumptions used in the resource impact template. Users can amend the 'Inputs and eligible population' and 'Unit costs' worksheets in the template to reflect ...

This summary report is based on the NICE assumptions used in the resource impact template. Users can amend the 'Inputs and eligible population' and 'Unit costs' worksheets in the template to reflect ...

The evaluation committee considered evidence submitted by Daiichi Sankyo, a review of this submission by the external assessment group (EAG), and responses from stakeholders. See the committee papers ...